10-K Filing

Dominari Holdings Inc. CIK: 12239 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001213900-21-017738`
Period End Date	20201231
Filing Date	20210325
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	aiki-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 48 Income Statement 28 Cash Flow Statement 58 Stockholders Equity 25

Balance Sheet 48 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.00K	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$857.00K	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$24.80M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$215.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$181.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.73M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Investments	`Investments`	$2.76M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Investments	`Investments`	$10.15M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	4.83M	shares	Point-in-time
Total assets	`Assets`	$30.50M	USD	Point-in-time
Total assets	`Assets`	$11.28M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	34.92M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	34.92M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	4.83M	shares	Point-in-time
Treasury stock	`TreasuryStockShares`	3.00	shares	Point-in-time
Treasury stock	`TreasuryStockShares`	3.00	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$567.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$68.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$682.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$310.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$877.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$750.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$877.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$750.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 34,920,222 and 4,825,552 shares issued at December 31, 2020 and 2019, respectively; 34,920,219 and 4,825,549 shares outstanding at December 31, 2020 and 2019, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 34,920,222 and 4,825,552 shares issued at December 31, 2020 and 2019, respectively; 34,920,219 and 4,825,549 shares outstanding at December 31, 2020 and 2019, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$186.48M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$155.06M	USD	Point-in-time
Treasury stock, at cost, 3 shares at December 31, 2020 and 2019	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 3 shares at December 31, 2020 and 2019	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-156.60M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-144.27M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$29.62M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.53M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.10M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$30.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.28M	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	Annual
Revenues	`Revenues`	$9.00K	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$4.06M	USD	Annual
General and administrative	`SellingGeneralAndAdministrativeExpense`	$3.17M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$10.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.02M	USD	Annual
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.47M	USD	Annual
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$2.51M	USD	Annual
Total operating expenses	`OperatingExpenses`	$6.55M	USD	Annual
Total operating expenses	`OperatingExpenses`	$5.69M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-6.55M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-5.68M	USD	Annual
Other income	`OtherIncome`	-	USD	Annual
Other income	`OtherIncome`	$19.00K	USD	Annual
Gains on marketable securities	`MarketableSecuritiesGainLoss`	$14.00K	USD	Annual
Gains on marketable securities	`MarketableSecuritiesGainLoss`	$1.00M	USD	Annual
Change in fair value of investment	`GainLossOnInvestments`	$1.41M	USD	Annual
Change in fair value of investment	`GainLossOnInvestments`	$-6.81M	USD	Annual
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-82.00K	USD	Annual
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$1.50M	USD	Annual
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$-5.79M	USD	Annual
Net loss	`NetIncomeLoss`	$-12.34M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.18M	USD	Annual
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.44	USD	Annual
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.67	USD	Annual
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.51M	shares	Annual
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	28.07M	shares	Annual

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-12.34M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.18M	USD	Annual
Change in fair value of investment	`ChangeInFairValueOfInvestment`	$1.41M	USD	Annual
Change in fair value of investment	`ChangeInFairValueOfInvestment`	$-6.81M	USD	Annual
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	$82.00K	USD	Annual
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	-	USD	Annual
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$2.51M	USD	Annual
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.47M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$84.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$329.00K	USD	Annual
Realized (gain) loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-172.00K	USD	Annual
Realized (gain) loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$509.00K	USD	Annual
Unrealized loss (gain) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$145.00K	USD	Annual
Unrealized loss (gain) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-218.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$34.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-7.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$499.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-64.00K	USD	Annual
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-50.00K	USD	Annual
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-372.00K	USD	Annual
Payable to DatChat	`IncreaseDecreaseInPayableToDatchat`	$-150.00K	USD	Annual
Payable to DatChat	`IncreaseDecreaseInPayableToDatchat`	$107.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.02M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.02M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$8.46M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$98.83M	USD	Annual
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$10.28M	USD	Annual
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$74.87M	USD	Annual
Sale of Hoth common shares	`ProceedsFromSaleOfCommonStock`	$460.00K	USD	Annual
Sale of Hoth common shares	`ProceedsFromSaleOfCommonStock`	-	USD	Annual
Purchase of investments at fair value	`PaymentsToAcquiresInvestment`	-	USD	Annual
Purchase of investments at fair value	`PaymentsToAcquiresInvestment`	$200.00K	USD	Annual
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$1.47M	USD	Annual
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$360.00K	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.26M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-24.96M	USD	Annual
Proceeds from issuance common stock, common warrants and prefunded warrants, net of offering cost	`ProceedsFromIssuanceCommonStockCommonWarrantsAndPrefundedWarrantsNetOfOfferingCost`	$6.56M	USD	Annual
Proceeds from issuance common stock, common warrants and prefunded warrants, net of offering cost	`ProceedsFromIssuanceCommonStockCommonWarrantsAndPrefundedWarrantsNetOfOfferingCost`	-	USD	Annual
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$787.00K	USD	Annual
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$17.84M	USD	Annual
Proceeds from issuance common stock/ At-the-market offering	`ProceedsFromIssuanceCommonStockAtthemarketOffering`	$-1.15M	USD	Annual
Proceeds from issuance common stock/ At-the-market offering	`ProceedsFromIssuanceCommonStockAtthemarketOffering`	-	USD	Annual
Offering costs from the issuance of common stock / At-the-market offering	`OfferingCostsFromIssuanceOfCommonStockAtthemarketOffering`	$106.00K	USD	Annual
Offering costs from the issuance of common stock / At-the-market offering	`OfferingCostsFromIssuanceOfCommonStockAtthemarketOffering`	-	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.20M	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.83M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$31.61M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$74.00K	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$2.62M	USD	Annual
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.00K	USD	Point-in-time
Distribution of Hoth common stock	`DistributionOfHothCommonStock`	$269.00K	USD	Annual
Distribution of Hoth common stock	`DistributionOfHothCommonStock`	$1.70M	USD	Annual

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Issuance of common stock and prefunded warrants net of offering cost	`IssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCost`	$941.00K	USD	Annual
Issuance of common stock, net of offering cost	`IssuanceOfCommonStockNetOfOfferingCost`	$1.91M	USD	Annual
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.10M	USD	Point-in-time
Issuance of common stock, common warrants and prefunded warrants, net of offering cost (net of offering costs of $941)	`StockIssuedDuringPeriodValueNewIssues2`	$6.56M	USD	Annual
Issuance of common stock, common warrants and prefunded warrants, net of offering cost (net of offering costs of $941)	`StockIssuedDuringPeriodValueNewIssues2`	$787.00K	USD	Annual
Issuance of common stock, net of offering cost (net of offering costs of $1,905)	`StockIssuedDuringPeriodValueNewIssues`	$1.05M	USD	Annual
Issuance of common stock, net of offering cost (net of offering costs of $1,905)	`StockIssuedDuringPeriodValueNewIssues`	$17.84M	USD	Annual
Issuance of common stock, net of offering cost (net of offering costs of $1,905), Shares	`StockIssuedDuringPeriodSharesNewIssues`	-	shares	Annual
Common warrant and prefunded warrant exercise	`CommonWarrantAndPrefundedWarrantExercise`	$7.20M	USD	Annual
Issuance of common stock for research and development - license acquired	`IssuanceOfCommonStockForResearchAndDevelopmentLicenseAcquired`	$2.15M	USD	Annual
Exercise of prefunded common stock warrants	`ExerciseOfPrefundedCommonStockWarrants`	-	USD	Annual
Warrant exercise	`StockIssuedDuringPeriodValueOfCommonWarrantAndPrefundedWarrantExercise`	-	USD	Annual
Exchange of common shares for prefunded warrants	`StockIssuedDuringExerciseOfPrefundedCommonStockWarrants`	-	USD	Annual
Distribution of Hoth common stock	`StockIssuedDuringDistributionOfHothCommonStock`	$-269.00K	USD	Annual
Distribution of Hoth common stock	`StockIssuedDuringDistributionOfHothCommonStock`	$-1.70M	USD	Annual
Fractional shares adjusted for reverse split	`AdjustmentsToAdditionalPaidInCapitalStockSplit`	-	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$329.00K	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$84.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-12.34M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.18M	USD	Annual
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.10M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.